Key result
In dialysis patients without ischemic heart disease, cTnI was the most specific marker (elevated in 4%), whereas cTnT was frequently elevated (up to 71%) due to skeletal muscle expression.
Why the study?
Does skeletal muscle expression of cTnT explain elevated serum cTnT in dialysis patients without ischemic heart disease?
Cross-Sectional (n=29)
Does skeletal muscle expression of cTnT explain elevated serum cTnT in dialysis patients without ischemic heart disease?
In dialysis patients without ischemic heart disease, cTnI is a more specific biomarker for myocardial injury than cTnT, as cTnT is frequently elevated due to its expression in skeletal muscle.
No takes yet. Share an insight, caveat, or question.
May support cTnI over cTnT for specificity in dialysis; hypothesis-generating pending prospective validation.
McLaurin et al. (1997) conducted a cross-sectional in Chronic dialysis without acute ischemic heart disease (n=29). Chronic dialysis was evaluated on Serum marker concentration above the upper reference limit. In dialysis patients without ischemic heart disease, cTnI was the most specific marker (elevated in 4%), whereas cTnT was frequently elevated (up to 71%) due to skeletal muscle expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: